Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Live attenuated versus killed virus vaccines.

R Thomssen

    Monographs in Allergy
    |January 1, 1975
    PubMed
    Summary

    Live and killed virus vaccines offer theoretically equivalent safety and potency. Currently, live vaccines provide greater potency, while killed vaccines are safer, though exceptions exist for specific applications.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Hepatitis B. The HBV-infected surgeon--risk of infection for the patient].

    Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2002
    Same author

    Effect of heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) apheresis on hepatitis C plasma virus load.

    Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis·2002
    Same author

    Differentiation in murine mastocytoma induced by macrophage gangliosides.

    Zeitschrift fur Naturforschung. C, Journal of biosciences·2001
    Same author

    Reduction of hepatitis C virus load by H.E.L.P.-LDL apheresis.

    European journal of clinical investigation·2001
    Same author

    Binding of human lipoproteins (low, very low, high density lipoproteins) to recombinant envelope proteins of hepatitis C virus.

    Medical microbiology and immunology·2000
    Same author

    Lack of clinical evidence for involvement of hepatitis C virus interferon-alpha sensitivity-determining region variability in RNA-dependent protein kinase-mediated cellular antiviral responses.

    Journal of medical virology·2000

    Area of Science:

    • Virology
    • Immunology
    • Vaccine Development

    Background:

    • Production and usage challenges of killed and live virus vaccines.
    • Theoretical equivalence in potency and safety between alternative vaccination strategies.

    Purpose of the Study:

    • To compare the current developmental stages of live and killed virus vaccines.
    • To analyze the relative advantages and disadvantages of each vaccine type.

    Main Methods:

    • Comparative analysis of theoretical concepts.
    • Evaluation of current developmental status in vaccine production and use.

    Main Results:

    • Live viral vaccines currently demonstrate superior potency.
    • Killed virus vaccines exhibit a higher safety profile.
    • Limitations exist, with live virus vaccines being safer in certain procedures.

    Conclusions:

    • While theoretically equal, practical differences in potency and safety persist between live and killed virus vaccines.
    • The choice of vaccine depends on specific application and risk-benefit analysis.
    • Ongoing research may further refine the safety and efficacy profiles of both vaccine types.

    Related Experiment Videos